Revisiting the role of FVIII in Haemophilia A in 2026

from EAHAD · host EAHAD - European Association for Haemophilia and Allied Disorders

In this episode, Cedric Hermans sits down with Jan Blatný, Consultant Haematologist at Masaryk University and University Hospital Brno, EHCC and EuroBloodNet Centre, and former EAHAD President (2024–2026), to explore the evolving role of Factor VIII in the management of haemophilia A in 2026. As new therapies such as emicizumab, rebalancing agents, and gene therapy reshape the treatment landscape, this conversation revisits where FVIII remains essential.

Episode metadata supplied by the publisher feed · Published Mar 28, 2026

Embed this episode

Attribution link and audio player

Ready to play

Revisiting the role of FVIII in Haemophilia A in 2026

0:00 25:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of EAHAD?

This episode is 25 minutes long.

When was this EAHAD episode published?

This episode was published on March 28, 2026.

Can I download this EAHAD episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!